Datenmanagement im Rahmen eines Transregios an der Universität Leipzig, der TU Chemnitz und dem Leibniz Institut für Oberflächenmodifizierung e.V. (IOM)

Posterbeitrag, welcher das Datenmanagement im Rahmen eines geplanten Transregios zwischen der Universität Leipzig, der TU Chemnitz und des Leibniz Instituts für Oberflächenmodifizierung skizziert

Implementation of health-related quality of life in the German TraumaRegister DGU® - first results of a pilot study

BACKGROUND Approximately 30,000 people are affected by severe injuries in Germany each year. Continuous progress in prehospital and hospital care has significantly reduced the mortality of polytrauma patients. With increasing survival rates, the functional outcome, health-related quality (hrQoL) of life and ability to work are now gaining importance. Aim of the study is, the presentation of the response behavior of seriously injured patients on the one hand and the examination of the factors influencing the quality of life and ability to work 12 months after major trauma on the other hand. Building on these initial results, a standard outcome tool shall be integrated in the established TraumaRegister DGU® in the future. METHODS In 2018, patients [Injury Severity Score (ISS) ≥ 16; age:18-75 years] underwent multicenter one-year posttraumatic follow-up in six study hospitals. In addition to assessing hrQoL by using the Short-Form Health Survey (SF-12), five additional questions (treatment satisfaction; ability to work; trauma-related medical treatment; relevant physical disability, hrQoL as compared with the prior to injury status) were applied. RESULTS Of the 1,162 patients contacted, 594 responded and were included in the analysis. The post-injury hrQoL does not show statistically significant differences between the sexes. Regarding age, however, the younger the patient at injury, the better the SF-12 physical sum score. Furthermore, the physically perceived quality of life decreases statistically significantly in relation to the severity of the trauma as measured by the ISS, whereas the mentally perceived quality of life shows no differences in terms of injury severity. A large proportion of severely injured patients were very satisfied (42.2%) or satisfied (39.9%) with the treatment outcome. It should be emphasized that patients with a high injury severity (ISS > 50) were on average more often very satisfied with the treatment outcome (46.7%). A total of 429 patients provided information on their ability to work 12 months post-injury. Here, 194 (45.2%) patients had a full employment, and 58 (13.5%) patients were had a restricted employment. CONCLUSION The present results show the importance of a structured assessment of the postinjury hrQoL and the ability to work after polytrauma. Further studies on the detection of influenceable risk factors on hrQoL and ability to work in the intersectoral course of treatment should follow to enable the best possible outcome of polytrauma survivors

Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats

Gadolinium based contrast agents (GBCAs) are widely used in clinical MRI since the mid-1980s. Recently, concerns have been raised that trace amounts of Gadolinium (Gd), detected in brains even long time after GBCA application, may cause yet unrecognized clinical consequences. We therefore assessed the behavioral phenotype, neuro-histopathology, and Gd localization after repeated administration of linear (gadodiamide) or macrocyclic (gadobutrol) GBCA in rats. While most behavioral tests revealed no difference between treatment groups, we observed a transient and reversible decrease of the startle reflex after gadodiamide application. Residual Gd in the lateral cerebellar nucleus was neither associated with a general gene expression pathway deregulation nor with neuronal cell loss, but in gadodiamide-treated rats Gd was associated with the perineuronal net protein aggrecan and segregated to high molecular weight fractions. Our behavioral finding together with Gd distribution and speciation support a substance class difference for Gd presence in the brain after GBCA application

RENEB accident simulation exercise

Purpose: The RENEB accident exercise was carried out in order to train the RENEB participants in coordinating and managing potentially large data sets that would be generated in case of a major radiological event. Materials and methods: Each participant was offered the possibility to activate the network by sending an alerting email about a simulated radiation emergency. The same participant had to collect, compile and report capacity, triage categorization and exposure scenario results obtained from all other participants. The exercise was performed over 27 weeks and involved the network consisting of 28 institutes: 21 RENEB members, four candidates and three non-RENEB partners. Results: The duration of a single exercise never exceeded 10 days, while the response from the assisting laboratories never came later than within half a day. During each week of the exercise, around 4500 samples were reported by all service laboratories (SL) to be examined and 54 scenarios were coherently estimated by all laboratories (the standard deviation from the mean of all SL answers for a given scenario category and a set of data was not larger than 3 patient codes). Conclusions: Each participant received training in both the role of a reference laboratory (activating the network) and of a service laboratory (responding to an activation request). The procedures in the case of radiological event were successfully established and tested

Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy

Antibodies are essential molecules for diagnosis and treatment of diseases caused by pathogens and their toxins. Antibodies were integrated in our medical repertoire against infectious diseases more than hundred years ago by using animal sera to treat tetanus and diphtheria. In these days, most developed therapeutic antibodies target cancer or autoimmune diseases. The COVID-19 pandemic was a reminder about the importance of antibodies for therapy against infectious diseases. While monoclonal antibodies could be generated by hybridoma technology since the 70ies of the former century, nowadays antibody phage display, among other display technologies, is robustly established to discover new human monoclonal antibodies. Phage display is an in vitro technology which confers the potential for generating antibodies from universal libraries against any conceivable molecule of sufficient size and omits the limitations of the immune systems. If convalescent patients or immunized/infected animals are available, it is possible to construct immune phage display libraries to select in vivo affinity-matured antibodies. A further advantage is the availability of the DNA sequence encoding the phage displayed antibody fragment, which is packaged in the phage particles. Therefore, the selected antibody fragments can be rapidly further engineered in any needed antibody format according to the requirements of the final application. In this review, we present an overview of phage display derived recombinant antibodies against bacterial, viral and eukaryotic pathogens, as well as microbial toxins, intended for diagnostic and therapeutic applications

Ancient Plasmodium genomes shed light on the history of human malaria

Malaria-causing protozoa of the genus Plasmodium have exerted one of the strongest selective pressures on the human genome, and resistance alleles provide biomolecular footprints that outline the historical reach of these species1. Nevertheless, debate persists over when and how malaria parasites emerged as human pathogens and spread around the globe1,2. To address these questions, we generated high-coverage ancient mitochondrial and nuclear genome-wide data from P. falciparum, P. vivax and P. malariae from 16 countries spanning around 5,500 years of human history. We identified P. vivax and P. falciparum across geographically disparate regions of Eurasia from as early as the fourth and first millennia bce, respectively; for P. vivax, this evidence pre-dates textual references by several millennia3. Genomic analysis supports distinct disease histories for P. falciparum and P. vivax in the Americas: similarities between now-eliminated European and peri-contact South American strains indicate that European colonizers were the source of American P. vivax, whereas the trans-Atlantic slave trade probably introduced P. falciparum into the Americas. Our data underscore the role of cross-cultural contacts in the dissemination of malaria, laying the biomolecular foundation for future palaeo-epidemiological research into the impact of Plasmodium parasites on human history. Finally, our unexpected discovery of P. falciparum in the high-altitude Himalayas provides a rare case study in which individual mobility can be inferred from infection status, adding to our knowledge of cross-cultural connectivity in the region nearly three millennia ago.This project was funded by the National Science Foundation, grants BCS-2141896 and BCS-1528698; the European Research Council (ERC) under the European Union’s Horizon 2020 programme, grants 851511-MICROSCOPE (to S. Schiffels), 771234-PALEoRIDER (to W.H.) and starting grant 805268-CoDisEASe (to K.I.B.); and the ERC starting grant Waves ERC758967 (supporting K. Nägele and S.C.). We thank the Max Planck-Harvard Research Center for the Archaeoscience of the Ancient Mediterranean for supporting M. Michel, E. Skourtanioti, A.M., R.A.B., L.C.B., G.U.N., N.S., V.V.-M., M. McCormick, P.W.S., C.W. and J.K.; the Kone Foundation for supporting E.K.G. and A.S.; and the Faculty of Medicine and the Faculty of Biological and Environmental Sciences at the University of Helsinki for grants to E.K.G. A.S. thanks the Magnus Ehrnrooth Foundation, the Sigrid Jusélius Foundation, the Finnish Cultural Foundation, the Academy of Finland, the Life and Health Medical Foundation and the Finnish Society of Sciences and Letters. M.C.B. acknowledges funding from: research project PID2020-116196GB-I00 funded by MCIN/AEI/10.13039/501100011033; the Spanish Ministry of Culture; the Chiang Ching Kuo Foundation; Fundación Palarq; the EU FP7 Marie Curie Zukunftskolleg Incoming Fellowship Programme, University of Konstanz (grant 291784); STAR2-Santander Universidades and Ministry of Education, Culture and Sports; and CEI 2015 project Cantabria Campus Internacional. M.E. received support from the Czech Academy of Sciences award Praemium Academiae and project RVO 67985912 of the Institute of Archaeology of the Czech Academy of Sciences, Prague. This work has been funded within project PID2020-115956GB-I00 ‘Origen y conformación del Bronce Valenciano’, granted by the Ministry of Science and Innovation of the Government of Spain, and grants from the Canadian Institutes for Health Research (MZI187236), Research Nova Scotia (RNS 2023-2565) and The Center for Health Research in Developing Countries. D.K. is the Canada research chair in translational vaccinology and inflammation. R.L.K. acknowledges support from a 2019 University of Otago research grant (Human health and adaptation along Silk Roads, a bioarchaeological investigation of a medieval Uzbek cemetery). P.O. thanks the Jane and Aatos Erkko Foundation, the Finnish Cultural Foundation and the Academy of Finland. S. Peltola received support from the Emil Aaltonen Foundation and the Ella and Georg Ehrnrooth Foundation. D.C.S.-G. thanks the Generalitat Valenciana (CIDEGENT/2019/061). E.W.K. acknowledges support from the DEEPDEAD project, HERA-UP, CRP (15.055) and the Horizon 2020 programme (grant 649307). M. Spyrou thanks the Elite program for postdocs of the Baden-Württemberg Stiftung. Open access funding provided by Max Planck Society

ELECTRIC MOBILITY IN GERMANY: UNDERSTANDING PIONEERS AND MARKET NICHES IN COMMERCIAL TRAFFIC

Innovations theories focusing on socio-technical regimes assume niches to be an initial point for social changes and innovations’ development becoming a mass market. This paper uses the niches approach and analyzes electric mobility in commercial transport in Germany. The central question is: Which niches are (not) addressed (yet)? Challenges are to identify current niches in commercial sector which are addressed by electric mobility and to determine further potentials for the niches identified. For this purpose two surveys have been evaluated and compared in the paper: one addressing the pioneers of battery electric vehicles (BEV) and one addressing owners of vehicles with internal combustion engines (ICEV) (evaluation limited to commercial users). One central finding of the analysis is that extreme and cost-inefficient use profiles are overrepresented among BEV pioneers as compared to all commercial vehicle owners. It is reflected in their purchase motivation: current pioneers are primarily motivated by environmental and image aspects than of rational economic reasons. Further, the analysis shows a great potential for the niches to expand. But this potential is not activated by current vehicle concepts. This paper provides results giving specific information about niche potentials and which motivating aspect could target them. To expand niches future research activities and policy measures should focus on demand-targeted measures and experiments towards a demand-targeted variety of car-concepts. Of special relevance for niche expansion are public or public related branches. Within innovation theories a demand by state organisations and authorities is an important initial demand for radical innovations

Acetabular Revision With Intramedullary and Extramedullary Iliac Fixation for Pelvic Discontinuity

EINLEITUNG: Hüftrevisionseingriffe nehmen in den letzten Jahren stetig zu. Eine Beckendiskontinuität (PD „pelvic discontinuity“) stellt dabei eines der herausforderndsten Szenarien dar. Wir berichten über unsere klinischen Ergebnisse mit einer asymmetrischen Hüftpfannenkomponente zur Behandlung der PD. Das Implantat ist mit einer extramedullären anatomisch geformten Lasche ausgestattet, die an der glutealen Oberfläche des Iliums fixiert wird. Eine zusätzliche Fixierung kann durch die Implantation eines intramedullären iliakalen Darmbeinzapfens erfolgen. MATERIAL UND METHODEN: In einer monozentrischen retrospektiven Kohortenstudie analysierten wir prospektiv erhobene Daten von 49 Pat. (35 weiblich, 14 männlich) mit unilateraler periprothetischer Beckendiskontinuität, die 2009-2017 mittels einer asymmetrischen Acetabulumkomponente operativ behandelt wurden. Das mittlere Alter der Betroffenen zum Zeitpunkt der Indexoperation betrug 72 Jahre (54- 90 Jahre). Die mittlere Nachbeobachtungszeit lag bei 71 Monaten (21-114 Monate). Sämtliche in der Folge aufgetretenen Komplikationen wurden dokumentiert und die radiologischen und funktionellen Ergebnisse (anhand des Harris Hip Scores (HHS) sowie der visuellen Analogskala für Schmerz (VAS)) wurden ausgewertet. ERGEBNISSE: Mittels Kaplan-Meier-Analyse konnte für unsere Studiengruppe ein 5-Jahres-Implantatüberleben von 91% (Konfidenzintervall 77%-96%) festgestellt werden). Der mittlere HHS verbesserte sich in unserem Patient*innenkollektiv von 41 präoperativ auf 79 bei der letzten Nachuntersuchung (p< .001); die VAS verbesserte sich hochsignifikant von einem Mittelwert von sechs präoperativ auf postoperativ eins (p< .001). Die Gesamtrevisionsrate betrug 16% (n=8). Zwei der Pat. benötigten eine Revision bei aseptischer Lockerung. Bei vier Pat. (8%) wurde eine periprothetische Infektion festgestellt: ein Patient wurde deshalb mit einer zweizeitigen Revision und ein weiterer mit einer Resektionsarthroplastik behandelt. Die anderen zwei Pat. wurden jeweils mit einem chirurgischen Eingriff im Sinne eines Debridements, ausgiebiger Spülung sowie dem Austausch der mobilen Teile behandelt. Von sechs Pat. (12%), die eine Hüftluxation erlitten, war bei zweien die Implantation einer Dual-Mobility-Acetabulumkomponente erforderlich. DISKUSSION: Wir konnten für die Implantation des hier beschriebenen Systems gute Ergebnisse für einen mittelfristigen Nachuntersuchungszeitraum nachweisen. In Zukunft könnte diese Technik die bereits etablierten Vorgehensweisen zur Behandlung der chronischen Beckendiskontinuität ergänzen und auch bei Pat. mit akut auftretender Diskontinuität oder periprothetischer Acetabulumfraktur eingesetzt werden.INTRODUCTION: Parallel to the increase in revision hip procedures surgeons face more and more complex anatomical challenges with pelvic discontinuity (PD) being one of the worst-case scenarios. Here we report on our clinical results using an asymmetric acetabular component for the treatment of PD. The implant is armed in a monoblock fashion with an extramedullary iliac flange and provides the possibility to augment it with an intramedullary iliac press-fit stem. MATERIAL AND METHODS: In a single-center retrospective cohort study we analyzed prospectively collected data of 49 patients (35 female, 14 male) suffering from unilateral periprosthetic PD treated with an asymmetric acetabular component between 2009 and 2017. The mean follow-up was 71 months (21-114). Complications were documented and radiographic and functional outcomes were assessed. RESULTS: Kaplan-Meier analysis revealed a 5-year implant survival of 91% (confidence interval 77%-96%). The 5-year survival with revision for any cause was 87% (CI 74%-94%). The overall revision rate was 16% (n � 8). Two patients required acetabular component revision due to aseptic loosening. Four patients (8%) suffered from periprosthetic infection: one patient was treated with a 2-stage revision, and another one with resection arthroplasty. The other 2 patients were treated with debridement, irrigation, and exchange of the mobile parts. Of 6 patients (12%) suffering from hip dislocation, 2 required implantation of a dual mobility acetabular component. The mean Harris Hip Score improved from 41 preoperatively to 79 at the latest follow-up (P < .001). DISCUSSION: Our findings demonstrate that an asymmetric acetabular component with extramedullary and optional intramedullary iliac fixation is a reliable and safe treatment method for periprosthetic PD resulting in good clinical and radiographic mid-term results

Characterization of D-enantiomeric peptides binding to monomeric Amyloid beta (1-42) identified by a competitive mirror image phage display

Alzheimer's disease (AD) is the most prominent type of dementia in elderly people. Until now there is no curative therapy available.Amyloid beta (Aβ) is assumed to play a major role in the development and progression of the disease. Freely diffusible, toxic Aβ oligomers seem to have a major toxicological impact